Código QR

Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy

Cell therapies derived from induced pluripotent stem cells (iPSCs) offer a promising avenue in the field of regenerative medicine due to iPSCs’ expandability, immune compatibility, and pluripotent potential. An increasing number of preclinical and clinical trials have been carried out, exploring the...

Descripción completa

Guardado en:
Autores principales: Congshan Sun, Carlo Serra, Brianna Harley Kalicharan, Jeffrey Harding, Mahendra Rao
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI AG 2024-03-01
Colección:Cells
Materias:
iPSC
stem cell therapy
muscular dystrophy
preclinical studies
disease models
genetic modification
Acceso en línea:https://www.mdpi.com/2073-4409/13/7/596
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares